CD14+HLA-DRlow/- expression: A novel prognostic factor in chronic lymphocytic leukemia

Oncology Letters

Volumn 9, Issue 3, 2015, Pages 1167-1172

  Liu, Jinlin ^a   Zhou, Yonglie ^a   Huang, Qiang ^a   Qiu, Liannv ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

CD14+HLA DRlow ; Chronic lymphocytic leukemia; Prognostic factor

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; HLA DR ANTIGEN; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CD4+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MONOCLONAL B CELL LYMPHOCYTOSIS; PROTEIN EXPRESSION; SUPPRESSOR CELL; TUMOR GROWTH; UPREGULATION;

EID: 84921809304     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2808     Document Type: Article

References (14)

1. Rassenti LZ, Jain S, Keating MJ, et al: Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 112: 1923-1930, 2008.
2. Scrivener S, Goddard RV, Kaminski ER and Prentice AG: Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 44: 383-389, 2003.
3. Gabrilovich DI and Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174, 2009.
4. + T cells. Gastroenterology 135: 234-243, 2008.
5. Filipazzi P, Valenti R, Huber V, et al: Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol 25: 2546-2553, 2007.
6. +HLA-DR(low)/-monocytes in B-cell non-Hodgkin lymphoma. Blood 117: 872-881, 2011.
7. Jaffe ES: The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program: 523-531, 2009.
8. Hallek M, Cheson BD, Catovsky D, et al; International Workshop on Chronic Lymphocytic Leukemia: Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute - Working Group 1996 guidelines. Blood 111: 5446-5456, 2008.
9. Gharagozlou S, Kardar GA, Rabbani H and Shokri F: Molecular analysis of the heavy chain variable region genes of human hybridoma clones specific for coagulation factor VIII. Thromb Haemost 94: 1131-1137, 2005.
10. Ghia P and Caligaris-Cappio F: Monoclonal B-cell lymphocytosis: right track or red herring? Blood 119: 4358-4362, 2012.
11. Orchard JA, Ibbotson RE, Davis Z, et al: ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363: 105-111, 2004.
12. Damle RN, Wasil T, Fais F, et al: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94: 1840-1847, 1999.
13. Hallek M: Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies. Blood 122: 3723-3734, 2013.
14. Marx J: Cancer immunology. Cancer's bulwark against immune attack: MDS cells. Science 319: 154-156, 2008.